GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Short-Term Debt

LumiraDx (LumiraDx) Short-Term Debt : $301.4 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Short-Term Debt?

LumiraDx's Short-Term Debt for the quarter that ended in Jun. 2023 was $301.4 Mil.

LumiraDx's quarterly Short-Term Debt increased from Dec. 2022 ($0.1 Mil) to Mar. 2023 ($0.1 Mil) and increased from Mar. 2023 ($0.1 Mil) to Jun. 2023 ($301.4 Mil).

LumiraDx's annual Short-Term Debt declined from Dec. 2020 ($147.2 Mil) to Dec. 2021 ($0.2 Mil) and declined from Dec. 2021 ($0.2 Mil) to Dec. 2022 ($0.1 Mil).

LumiraDx Short-Term Debt Historical Data

The historical data trend for LumiraDx's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Short-Term Debt Chart

LumiraDx Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Short-Term Debt
- 147.24 0.19 0.08

LumiraDx Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.11 0.08 0.14 301.44

LumiraDx Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

LumiraDx Short-Term Debt Related Terms

Thank you for viewing the detailed overview of LumiraDx's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Short-Term Debt
Comparable Companies
DRIO XGN AKUMQ CHEK TTOO STIM OCX MYNZ TRIB CNTG TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
N/A
Address
C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108
Website
https://www.lumiradx.com
LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.